Jeff Carr is a global healthcare executive whose 25-year career has been committed to innovation in medical technologies and driven by a passion for pursuing solutions in areas of unmet need in healthcare. Jeff currently heads the Frenova Genomics and Precision Medicine program, an effort to catalyze greater investment in kidney health innovation through the development of the world’s largest renal registry. Since joining Fresenius Medical Care in 2016, he has held leadership roles within the company—in business development with the Renal Therapies Group and as a lead member of the Global Efficiency Program. Jeff’s previous positions include a management role with Alere, a global leader in point-of-care diagnostics (later acquired by Abbott Laboratories), where his focus was development and deployment of chronic disease management platforms with an emphasis on resource-limited settings. He earned his bachelor’s degree from the University of Maine and pursued graduate studies at Northeastern University’s D’Amore-McKim School of Business.